Healio1d
Rivaroxaban a ‘viable alternative’ to warfarin for blood clots after heart attack
In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular ...
Powerful Medical Receives FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model
Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been ...
News-Medical.Net8h
Rivaroxaban shown to be a viable alternative to warfarin for left ventricular thrombus
At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner ...
Physician's Weekly13d
Optimizing STEMI Care With Mission Lifeline Protocols in EMS
The following is a summary of “Continuous quality improvement for prehospital STEMI improved triage rates and achievement of ...
Healio1d
Three months may be the ‘sweet spot’ for dual antiplatelet therapy after PCI
Three months of dual antiplatelet therapy after PCI may safely balance thrombosis and bleeding risk in both patients with low ...
Morningstar5d
Powerful Medical Receives FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model
Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the US Food and Drug ...
AlphaGalileo1d
AI Model Shows High Accuracy in Heart Attack Detection
An artificial intelligence (AI) model trained to detect blocked coronary arteries based on electrocardiogram (ECG) readings performed better than ...